⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Sysmex Corporation and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Sysmex Corporation
↗Kobe, Japan
Sysmex Corporation is a global leader in the healthcare industry, specializing in in vitro diagnostics (IVD). The company develops, manufactures, and sells diagnostic instruments, reagents, and related software, with a dominant market position in hematology, hemostasis, and urinalysis.
Founded in 1968 and headquartered in Kobe, Japan, Sysmex operates in over 190 countries. Its business model is characterized by a 'razor-and-blade' strategy, where the installation of high-precision diagnostic analyzers drives long-term, recurring revenue from proprietary reagents, consumables, and service contracts. The company is increasingly pivoting toward personalized medicine, oncology, and AI-driven digital health solutions to support clinical decision-making.
CLASSIFICATION
SIZE & FINANCIALS
Employees:10000+
Revenue:~$3.3B
Founded:1968
Ownership:public
Status:operating
STOCK
Exchange:Tokyo Stock Exchange
Ticker:6869
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:Diagnostic instruments, Reagents, Software/Informatics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Sysmex America, Inc., Sysmex Europe SE
Key Partnerships:International Society on Thrombosis and Haemostasis (ISTH), Various hospital networks and research institutes for clinical validation
COMPETITION
Position:Leader
Competitors:Cepheid, Bruker, Sartorius, Siemens Healthineers
LEADERSHIP
Key Executives:
Hisashi Ietsugu - Chairperson and Group CEO
Kaoru Asano - President
LINKS
Website:sysmex.co.jp
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Sysmex Corporation. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.